Biofrontera AG
Biotechnology
Healthcare
BFRA
56.72M shares
NASDAQ US
traded
04 Mar 2022
listed
yes
open
3.10
52 week high
7.25
high
3.10
52 week low
2.50
previous Close
2.95
P/E ratio
-12
market cap
121M
div yield
0
net incoming
-5.73M
-43.48 %
net profit margin
-106.56 %
-54.00 %
operating incoming
-4.99M
-42.89 %
cash on hand
29.54M
-9.45 %
cost of revenue
699K
-37.08 %
top